Lumoptik's logo
Lumoptik

@lumoptik.com

Lumoptik has developed precision guidance systems for medical devices utilizing its patent-pending Light Assisted Breach Assessment (LABA) technology.

📢

Find anything inaccurate?

If you spot any mistakes on this brand profile, report to us.

Brand Logos

View all
 Lumoptik's logos

Logo

PNG

About

Description

Lumoptik is a leading medical device company dedicated to revolutionizing precision guidance systems. Their patented Light Assisted Breach Assessment (LABA) technology has paved the way for groundbreaking advancements in the field. Lumoptik's flagship product, the BrightPointTM needle guidance system, is designed to assist physicians during epidural procedures for childbirth, spine/back pain, and surgical procedures like knee and hip replacements.


With over 11 million epidural procedures performed in the US each year, Lumoptik recognizes the need for enhanced accuracy and safety. The BrightPointTM system offers a cost-effective and user-friendly solution, consisting of a reusable handheld controller and a disposable fiber optic light channel that fits seamlessly into existing epidural needles. Operating on the principles of light reflection, the BrightPointTM system provides real-time information on tissue types as the needle is inserted, giving physicians precise guidance for needle placement.


From skin to muscle and even into the epidural space, the controller screen displays color changes and a scrolling line graph to indicate the location of the needle tip. Importantly, Lumoptik's BrightPointTM system complements rather than replaces the manual Loss of Resistance (LOR) method currently used by anesthesiologists. It seamlessly integrates with existing needles and syringes, making it a versatile and valuable addition to medical professionals' toolkit.


Recognizing the far-reaching potential of their technology, Lumoptik envisions applications beyond epidural procedures. Their platform technology shows promise for urology catheter placement, orthopedic access, vascular access, cardiac catheter introduction, ophthalmic treatments, and even veterinary use. With a focus on continual innovation, Lumoptik aims to develop additional cutting-edge products to expand the company's value and attract major acquirers.


By prioritizing the launch of the BrightPointTM epidural needle guidance product, Lumoptik is poised to make a significant impact by reducing complications, increasing successful procedures, and improving patient outcomes

Read more...

Company Size

2-10

Year Founded

2012

Brand collections

View all

Logos

Colors

Fonts

Images